HIV patients treated with low-dose prednisolone exhibit lower immune activation than untreated patients (Q34134411)

31 July 2017

HIV patients treated with low-dose prednisolone exhibit lower immune activation than untreated patients (English)

1 reference

31 July 2017

7

Samuel Kalluvya

1 reference

31 July 2017

Christa Kasang

1

1 reference

ORCID Public Data File 2021

Barbara Schmidt

4

object named as

Barbara Schmidt

1 reference

31 July 2017

Albrecht Ulmer

2

1 reference

31 July 2017

Norbert Donhauser

3

1 reference

31 July 2017

August Stich

5

1 reference

31 July 2017

Hartwig Klinker

6

1 reference

31 July 2017

Eleni Koutsilieri

8

1 reference

31 July 2017

Axel Rethwilm

9

1 reference

31 July 2017

Carsten Scheller

10

1 reference

31 July 2017

20 January 2012

1 reference

31 July 2017

BMC Infectious Diseases

1 reference

31 July 2017

12

1 reference

31 July 2017

14

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2334-12-14

31 July 2017

0 references

cites work

Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3282641

Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3282641

The absence of CD4+ T cell count recovery despite receipt of virologically suppressive highly active antiretroviral therapy: clinical risk, immunological gaps, and therapeutic options

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3282641

Microbial translocation is a cause of systemic immune activation in chronic HIV infection

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3282641

Failure to reconstitute CD4+ T-cells despite suppression of HIV replication under HAART.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3282641

Modulatory effects of sCD14 and LBP on LPS-host cell interactions

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3282641

The neuropathogenesis of AIDS

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3282641

A randomized, double-blind, placebo-controlled trial of the use of prednisolone as an adjunct to treatment in HIV-1-associated pleural tuberculosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3282641

Long-term clinical, immunologic and virologic impact of glucocorticoids on the chronic phase of HIV infection

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3282641

Persistent immune activation in HIV-1 infection is associated with progression to AIDS.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3282641

T Cell Activation Is Associated with Lower CD4+T Cell Gains in Human Immunodeficiency Virus–Infected Patients with Sustained Viral Suppression during Antiretroviral Therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3282641

The immunopathogenesis of sepsis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3282641

Levels of soluble CD40 ligand (CD154) in serum are increased in human immunodeficiency virus type 1-infected patients and correlate with CD4(+) T-cell counts

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3282641

Double blind randomised placebo controlled trial of adjunctive prednisolone in the treatment of effusive tuberculous pericarditis in HIV seropositive patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3282641

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3282641

Activation of CD8 T cells normalizes and correlates with the level of infectious provirus in tonsils during highly active antiretroviral therapy in early HIV-1 infection

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3282641

Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3282641

Elevated levels of serum-soluble CD14 in human immunodeficiency virus type 1 (HIV-1) infection: correlation to disease progression and clinical events

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3282641

Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trials Group Protocol 315.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3282641

Multifactorial nature of human immunodeficiency virus disease: implications for therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3282641

Recombinant soluble trimeric CD40 ligand is biologically active

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3282641

Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia.

5 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-14

Highly active antiretroviral therapy during early HIV infection reverses T-cell activation and maturation abnormalities. Swiss HIV Cohort Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-14

Changes in CD4+ and CD8+ T cell subsets in response to highly active antiretroviral therapy in HIV type 1-infected patients with prior protease inhibitor experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-14

Changes in CD8 cell subpopulations induced by antiretroviral therapy in human immunodeficiency virus infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-14

Effect of baseline- and treatment-related factors on immunologic recovery after initiation of antiretroviral therapy in HIV-1-positive subjects: results from ACTG 384.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-14

Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-14

Survival of persons with and without HIV infection in Denmark, 1995-2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-14

Sustained increases in CD4 cell counts in asymptomatic human immunodeficiency virus type 1-seropositive patients treated with prednisolone for 1 year

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-14

Placebo-controlled trial of prednisone in advanced HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-14

A study of the immunology, virology, and safety of prednisone in HIV-1-infected subjects with CD4 cell counts of 200 to 700 mm(-3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-14

Immunological and virological features of HIV-infected patients with increasing CD4 cell numbers despite virological failure during protease inhibitor-based therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-14

Plasma levels of soluble CD14 and tumor necrosis factor-alpha type II receptor correlate with cognitive dysfunction during human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-14

High levels of SIVmnd-1 replication in chronically infected Mandrillus sphinx

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-14

Disruption of excitatory amino acid transporters in brains of SIV-infected rhesus macaques is associated with microglia activation.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3282641

Low-dose prednisolone has a CD4-stabilizing effect in pre-treated HIV-patients during structured therapy interruptions (STI).

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3282641

Low dose prednisolone reduces CD4+ T cell loss in therapy-naive HIV-patients without antiretroviral therapy

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3282641

High Plasma Levels of Intact and Cleaved Soluble Urokinase Receptor Reflect Immune Activation and Are Independent Predictors of Mortality in HIV-1-Infected Patients

28 October 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-14

Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-14

CD4 T-cell hyperactivation and susceptibility to cell death determine poor CD4 T-cell recovery during suppressive HAART

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-14

Limited immune restoration after 3 years' suppression of HIV-1 replication in patients with moderately advanced disease

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22264238

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22264238

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2334-12-14

1 reference

Dimensions Publication ID

31 July 2017

0 references

1 reference

31 July 2017

1 reference